Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

MiMedx postpones release of Q4 results on internal investigation into sales/distribution practices; shares halted

Published 02/20/2018, 08:52 AM
© Reuters.  MiMedx postpones release of Q4 results on internal investigation into sales/distribution practices; shares halted
MDXG
-
  • Nasdaq has suspended trading in MiMedx Group (NASDAQ:MDXG) after it announced that has postponed the release of its Q4 and 2017 results after the Board's Audit Committee engaged outside legal and accounting advisors to investigate certain matters related to the company's sales and distribution practices. Executives are also reviewing the accounting treatment of certain distributor contracts.
  • Financial results will not be released until the internal investigation has been completed.
  • Previously: MiMedx reports preliminary 2017 revenue of $324.5M (Jan. 8)
  • Now read: Masimo Corporation: A Case Study


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.